Streetbeat News

Regulatory

GOOG

The U.S. Department of Justice has officially filed a proposal to break up Google's monopoly on search, suggesting that Google should sell its Chrome browser. Google plans to contest this proposal.

Portfolio Pulse from

November 21, 2024 | 10:15 pm

ZVRA

Zevra Therapeutics has announced the U.S. commercial availability of MIPLYFFA, the first FDA-approved treatment for Niemann-Pick Disease Type C. The drug is now available through Zevra's specialty pharmacy.

Portfolio Pulse from

November 21, 2024 | 10:00 pm

CCG

Cheche Group Inc. (NASDAQ: CCG) has received a notification from Nasdaq for non-compliance with the minimum bid price requirement, as its stock has been below $1.00 for 30 consecutive business days. This does not result in immediate delisting.

Portfolio Pulse from

November 21, 2024 | 9:45 pm

AWR

American States Water Company announced a proposed decision from the California Public Utilities Commission regarding new water rates for its subsidiary, Golden State Water Company, for 2025-2027. A final decision is expected soon.

Portfolio Pulse from

November 21, 2024 | 9:45 pm

NDAQ

PEV

Phoenix Motor Inc. has received a delisting notice from Nasdaq due to its failure to file its quarterly report on time. This non-compliance with Nasdaq's listing rules could impact the company's stock price.

Portfolio Pulse from

November 21, 2024 | 9:30 pm

SPI

SPI Energy Co., Ltd. has received a delisting determination notice from Nasdaq, which could impact its stock price and investor confidence.

Portfolio Pulse from

November 21, 2024 | 9:30 pm

PANW

Nikesh Arora, CEO of Palo Alto Networks, suggests that mergers and acquisitions (M&A) could accelerate under the Trump administration due to a potential shift towards deregulation.

Portfolio Pulse from

November 21, 2024 | 9:15 pm

UNH

UnitedHealth Group is preparing for its December Investor Day, reiterating a buy recommendation. Despite facing regulatory challenges, rising medical costs, and a cyberattack, the company maintains growth and targets 13%-16% long-term earnings growth. Optum Insight and Optum Health segments face short-term hurdles but are poised for future growth.

Portfolio Pulse from

November 21, 2024 | 9:15 pm

PCRX

Levi & Korsinsky has initiated an investigation into Pacira BioSciences, Inc. (PCRX) for potential violations of federal securities laws. This follows a press release by Pacira on August 9, 2024, regarding a lawsuit outcome against eVenus for patent infringement.

Portfolio Pulse from

November 21, 2024 | 9:00 pm